Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Sales | 577 | 2,737 | 3,118 | 0 | 0 |
| Gross Profit | 577 | 2,737 | 3,118 | N/A | N/A |
| Operating Expenses | 31,564 | 29,004 | 19,521 | 0 | 0 |
| Operating Income | -30,987 | -26,267 | -16,403 | N/A | N/A |
| Interest Expense | 7 | 613 | 194 | 0 | 0 |
| Other Income | 304 | 30 | 39 | 0 | 0 |
| Pre-tax Income | -30,690 | -26,850 | -16,558 | 0 | 0 |
| Income Tax | 2 | 18 | 33 | N/A | N/A |
| Net Income Continuous | -30,692 | -26,868 | -16,591 | N/A | N/A |
| Net Income | $-30,692 | $-26,868 | $-16,591 | $N/A | $N/A |
| EPS Basic Total Ops | -1.07 | -1.56 | -2.96 | N/A | N/A |
| EPS Basic Continuous Ops | -1.07 | -1.56 | -2.96 | N/A | N/A |
| EPS Diluted Total Ops | -1.07 | -1.56 | -2.96 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.07 | -1.56 | -2.96 | N/A | N/A |
| EBITDA(a) | $-30,664 | $-26,244 | $-16,356 | $N/A | $N/A |